Literature DB >> 9309745

The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing.

B P Grubb1, D J Kosinski, K Boehm, K Kip.   

Abstract

Head upright tilt table testing has emerged as an accepted modality for identifying an individual's predisposition to episodes of autonomically mediated hypotension and bradycardia that are sufficiently profound so that transient loss of consciousness ensues (neurocardiogenic syncope). However it has also become apparent that less dramatic falls in blood pressure, while not sufficient to cause full syncope, may produce symptoms such as near syncope, vertigo, dizziness, and TIA-like episodes. We have identified a subgroup of individuals with a mild form of autonomic dysfunction with symptoms of postural tachycardia and lightheadedness, disabling fatigue, exercise intolerance, dizziness, and near syncope. During baseline tilt table testing these patients demonstrated a heart rate increase of > or = 30 beats/min (or a maximum heart rate of 120 beats/min) within the first 10 minutes upright (unassociated with profound hypotension), which reproduced their symptom complex. In addition these patients exhibit an exaggerated response to isoproterenol infusions. Similar observations have been made by others who have dubbed this entity the Postural Orthostatic Tachycardia Syndrome (POTS). We conclude that POTS represents a mild (and potentially treatable) from of autonomic dysfunction that can be readily diagnosed during head upright tilt table testing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9309745     DOI: 10.1111/j.1540-8159.1997.tb04238.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  24 in total

1.  The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders.

Authors:  R A Kenny; D O'Shea; S W Parry
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

Review 2.  Neurally mediated syncope.

Authors:  M Zaqqa; A Massumi
Journal:  Tex Heart Inst J       Date:  2000

3.  Vasodepressor Syncope.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

Review 4.  Chronic orthostatic intolerance and the postural tachycardia syndrome (POTS).

Authors:  Julian M Stewart
Journal:  J Pediatr       Date:  2004-12       Impact factor: 4.406

Review 5.  Postural orthostatic tachycardia syndrome.

Authors:  A K Agarwal; R Garg; A Ritch; P Sarkar
Journal:  Postgrad Med J       Date:  2007-07       Impact factor: 2.401

6.  Guidelines for the diagnosis and management of syncope (version 2009).

Authors:  Angel Moya; Richard Sutton; Fabrizio Ammirati; Jean-Jacques Blanc; Michele Brignole; Johannes B Dahm; Jean-Claude Deharo; Jacek Gajek; Knut Gjesdal; Andrew Krahn; Martial Massin; Mauro Pepi; Thomas Pezawas; Ricardo Ruiz Granell; Francois Sarasin; Andrea Ungar; J Gert van Dijk; Edmond P Walma; Wouter Wieling
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

7.  Low iron storage in children with tilt positive neurally mediated syncope.

Authors:  Baris Guven; Taliha Oner; Vedide Tavli; Murat Muhtar Yilmazer; Savas Demirpence; Timur Mese
Journal:  World J Pediatr       Date:  2012-12-29       Impact factor: 2.764

8.  P-wave dispersion: an indicator of cardiac autonomic dysfunction in children with neurocardiogenic syncope.

Authors:  Melis Demir Köse; Özlem Bağ; Barış Güven; Timur Meşe; Aysel Öztürk; Vedide Tavlı
Journal:  Pediatr Cardiol       Date:  2013-10-25       Impact factor: 1.655

Review 9.  The fainting patient: value of the head-upright tilt-table test in adult patients with orthostatic intolerance.

Authors:  M Lamarre-Cliche; J Cusson
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

10.  Joint hypermobility syndrome and dysautonomia: expanding spectrum of disease presentation and manifestation.

Authors:  Shomu Bohora
Journal:  Indian Pacing Electrophysiol J       Date:  2010-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.